Paclitaxel/multialkene paclitaxel liposome composite medicine and preparation method thereof

A liposome and drug technology, applied in the directions of liposome delivery, drug combination, pharmaceutical formulation, etc., can solve problems such as side effects, neutropenia, tumor cell death, etc. Exponentially high effect
CN100586430CInactive Publication Date: 2010-02-03HUNAN KANGDU PHARMA
1 Cites 2 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
HUNAN KANGDU PHARMA
Publication Date
2010-02-03
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a liposome drug combination and a preparation method of the drug combination. The weights of the effective drug components are listed as follows: the weight of the admixture for hydrogenated soybean phosphatide and sheep brain lecithin with a weight ratio of 2:1 is 300 to 550; the weight of the admixture for cholesterol, stearamide and beta-sitosterol with a weight ratio of 1:1:0.1 is 200 to 400; the weight of the admixture for tiopronin and vitamin E with a weight ratio of 4:1 is 100 to 200; the weight of the admixture for polyethylene glycol-4000 and polyethylene glycol-6000 with a discretional weight ratio is 150 to 200; the weight of vitamin C is 150 to 180; the weight of the admixture for tert-butyl alcohol and anhydrous alcohol with a weight ratio of 1.5 to 2.2:0.01 to 0.05 is 4000 to 7000; the weight of the admixture for paclitaxel and polyene paclitaxel with a discretional weight ratio is 20 and 40; the weight of the admixture for diphenhydramine and cimetidine with a weight ratio of 1:6 is 350 to 500. The invention has the advantages of reducing the drug dosage by nearly one time, increasing the curative effect by over 15 percent, and greatly reducing the side effect of the drugs.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a paclitaxel / docetaxel liposome combination drug and a preparation method thereof. Background technique

[0002] Paclitaxel or docetaxel is a broad-spectrum effective anticancer drug, which can act on the microtubule / tubulin system of tumor cells, promote the assembly of tubulin into microtubules, but at the same time inhibit the depolymerization of microtubules, resulting in the breakdown of microtubule bundles. Abnormal alignment, formation of stellate bodies, disabling the normal function of the spindle, leading to tumor cell death.

[0003] However, in the prior art, paclitaxel or docetaxel preparations are common injections, and 47% of people have decreased blood neutrophils after using this type of drug, and 62% of people have decreased blood neutrophils after using this type of drug. Systemic poisoning and numbness of the limbs, side effects on the liver, skin, and digestive system are common and obvious. In recent yea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More